We value our partners who share in our commitment to deliver therapeutics to patients in need
Through focused collaborations, we ensure that promising therapeutic opportunities reach their full potential, so that patients can have access to life-changing treatments.
Seprator Line
Our current portfolio is focused on addressing needs in oncology and non-opioid pain, but our singular vantage point enables us to pursue one-and-only opportunities across the therapeutic landscape. Target opportunities include approved products currently in market, as well as products in late-stage development. Our therapeutic areas of interest include, but are not limited to:
Oncology
Urology
Rare/orphan diseases
Non-opioid pain